Respiratory Therapy Hospital Market
Nebulizers
- $30 million in U.S.hospital annual sales of SVNs
- $200 million in drug ampoules for use with nebulizers
- Bronchodilators, Steroids, Mucolytics
Drugs in development / new to inhalation
- Large market potential in acute care setting
- Antibiotics
- Anti-inflammatory agents
- Surfactants
- Protease inhibitors